SCHEDULE: Contrarius Investment Discloses 8.9% Stake in QVC Group

Contrarius Investment Management entities have reported a combined beneficial ownership of 8.9% of QVC Group, Inc.'s Series A Common Stock as of September 30, 2025.

Summary

• Contrarius Investment Management Ltd and Contrarius Investment Management (Bermuda) Ltd, collectively referred to as Contrarius, have filed an Amendment No. 5 to Schedule 13G.
• Contrarius beneficially owns 702,768 shares of QVC Group, Inc.'s Series A Common Stock.
• This ownership represents 8.9% of the total class of Series A Common Stock.
• Contrarius holds shared voting power and shared dispositive power over all 702,768 shares.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing the control of QVC Group, Inc.

Sentiment

Score: 6

Explanation: The filing is a routine disclosure of a significant institutional ownership stake, indicating continued investor interest in QVC Group, Inc. without implying any immediate operational changes or financial performance updates.

Positives

• Significant institutional ownership by Contrarius Investment Management, holding 8.9% of QVC Group, Inc.'s Series A Common Stock.
• The investment is stated to be in the ordinary course of business, not for control purposes, suggesting a passive, long-term investment intent.

Future Outlook

This filing does not contain any forward-looking statements or guidance from QVC Group, Inc. regarding its future performance or strategic direction.

Industry Context

This filing is a routine disclosure of beneficial ownership by an institutional investor and does not provide specific insights into broader industry trends or competitive landscape for QVC Group, Inc.

Stakeholder Impact

• Shareholders: Increased transparency regarding significant institutional ownership. The presence of a large institutional investor may provide some stability or confidence in the company's stock.

Key Dates

Keywords

QVC Group, Contrarius Investment Management, Schedule 13G, Beneficial Ownership, Series A Common Stock, Institutional Investor, SEC Filing